Breast and Colon Cancer Family Registries

In Press/Accepted

• Bigler J, Curtin K, Ulrich CM, Caan B, Potter JD, Slattery ML. DNA repair polymorphisms, folate, and colon cancer risk. Cancer Epidemiol Biomarkers Prev (In Press).

2008

• Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008 Feb 1;26(4):665-73.

2007

• Boardman LA, Morlan BW, Rabe KG, Petersen GM, Lindor NM, Nigon SK, Goldberg J, Gallinger S. Colorectal Cancer Risks in Relatives of Young-Onset Cases: Is Risk the Same Across All First-Degree Relatives? Clin Gastroenterol Hepatol 2007 Oct;5(10):1195-8.
• Campbell PT, Cotterchio M, Dicks E, Parfrey P, Gallinger S, McLaughlin JR. Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2007 Sep;16(9):1735-44.
• Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR. Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 2007 Sep;18(7):723-33.
• Esplen MJ, Madlensky L, Aronson M, Rothenmund H, Gallinger S, Butler K, Toner B, Wong J, Manno M, McLaughlin J. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Genet 2007 Nov;72(5):394-401. Epub 2007 Sep 24.
• Glanz K, Steffen AD, Taglialatela LA. Effects of colon cancer risk counseling for first-degree relatives. Cancer Epidemiol Biomarkers Prev 2007 Jul;16(7):1485-91.
• Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer 2007;6(1):53-62.
• Greenwood CM, Rangrej J, Sun L. Optimal selection of markers for validation or replication from genome-wide association studies. Genet Epidemiol 2007 Jul;31(5):396-407.
• Jaskowski L, Young J, Jackson L, Arnold S, Barker MA, Walsh MD, Buchanan DD, Holman S, Mensink KA, Jenkins MA, Hopper JL, Thibodeau SN, Jass JR, Spurdle AB. Stability of BAT26 in Lynch syndrome colorectal tumours. Eur J Hum Genet 2007 Feb;15(2):139-41; author reply 141-2.
• Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR; Colon Cancer Family Registry. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007 Jul;133(1):48-56.
• Jenkins MA, Southey MC, Giles GG, Hopper JL. Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer. Curr Oncol Rep 2007 May;9(3):202-7.
• Kohut K, Manno M, Gallinger S, Esplen MJ. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry. J Med Genet 2007 Jun;44(6):404-7.
• Madlensky L, Daftary D, Burnett T, Harmon P, Jenkins M, Maskiell J, Nigon S, Phillips K, Templeton A, Limburg PJ, Haile RW, Potter JD, Gallinger S, Baron JA. Accuracy of Colorectal Polyp Self-Reports: Findings from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2007 Sep;16(9):1898-901.
• Mrkonjic M, Raptis S, Green RC, Monga N, Daftary D, Dicks E, Younghusband HB, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B. MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer. Carcinogenesis 2007 Dec;28(12):2575-80.
• Naja F, Krieger N, Sullivan T. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007 Aug;21(8):501-6.
• Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Lindor N, Potter JD, Templeton AS, Seminara D, Thibodeau S for the Colon Cancer Family Registry. Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer. Cancer Epidemiol Biomarkers Prev 2007 Nov;16(11):2331-2343.
• Ramsey SD, Howlader N, Etzioni R, Brown M, Warren J, Newcomb P. Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer. Cancer 2007 Jun 1;109(11):2222-8.
• Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B. MLH1 -93 G>A promoter polymorphism and the risk for microsatellite unstable colorectal cancer. J Natl Cancer Inst 2007 Mar;99(6):463-74.
• Saunders IW, Hannan GN, Brohede J, Giles GG, Jenkins MA, Hopper JL, Southey MC. A range of simple summary genome-wide statistics for detecting genetic linkage using high density marker data. Genet Epidemiol 2007 Sep;31(6):565-76.
• Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR, Younghusband HB. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 2007 Jul;28(7):669-73.
• Young JP, Jenkins MA, Parry S, Young BW, Nancarrow DJ, English DR, Giles GG, Jass JR. Serrated pathway colorectal cancer in the population: genetic consideration. Gut 2007 Oct;56(10):1453-9.
• Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, Robidoux F, Sladek R, Montpetit A, Campbell P, Bezieau S, O'Shea AM, Zogopoulos G, Cotterchio M, Newcomb P, McLaughlin J, Younghusband B, Green R, Green J, Porteous ME, Campbell H, Blanche H, Sahbatou M, Tubacher E, Bonaiti-Pellié C, Buecher B, Riboli E, Kury S, Chanock SJ, Potter J, Thomas G, Gallinger S, Hudson TJ, Dunlop MG. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007 Aug;39(8):989-94.
• Zogopoulos G, Ha KC, Naqib F, Moore S, Kim H, Montpetit A, Robidoux F, Laflamme P, Cotterchio M, Greenwood C, Scherer SW, Zanke B, Hudson TJ, Bader GD, Gallinger S. Germ-line DNA copy number variation frequencies in a large North American population. Hum Genet 2007 Nov;122(3-4):345-53.

2006

• Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor NM, Casey G, Ellis N, Giardiello FM, Offit K, Parmigiani G; Colon Cancer Family Registry. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006 Sep 27;296(12):1479-87.
• Chia VM, Newcomb PA, Bigler J, Morimoto LM, Thibodeau SN, Potter JD. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use. Cancer Res 2006 Jul 1;66(13):6877-83. 
• Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 2006 Dec;136(12):3046-53.
• Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 2006 Feb;17(1):63-70. 
• Esplen MJ. Mapping the human genome: psychosocial impacts and implications for nursing. Can J Nurs Res 2006 Jun;38(2):115-22.
• Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St. John DJ, Jass JR, Giles GG, Hopper JL, Southey MC. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 2006 Apr;4(4):489-98.
• Jenkins M, Croitoru M, Monga N, Cleary S, Cotterchio M, Hopper J, Gallinger S. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 2006 Feb;15(2):312-4.
• Jenkins MA, Macrae F, Young J, Barker M, Leggett B, Goldblatt J, Kirk J, Tucker K, Suthers G, Young G, Parry S, Arnold J, Winship I, Maskiell J, Giles G, Jass J, Hopper J. The Colon Cancer Family Registry, an international resource for studying the genetic and molecular epidemiology of colorectal cancer. Gastrointestinal Cancer Update 2006;46:14-20.
• Jenkins MA, Southey MC, Giles GG, Hopper JL. Rationale for, and approach to studying, modifiers of risk in persons with a genetic predisposition to colorectal cancer. Review Current Colorectal Cancer Reports 2006;2:173-8.
• Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006 Sep 27;296(12):1507-17. Review.
• Lindor NM, Smalley R, Barker M, Bigler J, Krumroy LM, Lum-Jones A, Plummer SJ, Selander T, Thomas S, Youash M, Seminara D, Casey G, Bapat B, Thibodeau SN. Ascending the learning curve—MSI testing experience of a six-laboratory consortium. Cancer Biomark 2006;2(1-2):5-9.
• Pastrello C, Baglioni S, Tibiletti MG, Papi L, Fornasarig M, Morabito A, Agostini M, Genuardi M, Viel A. Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. Eur J Hum Gene 2006 Jan;14(1):63-8
• Psaty BM, Potter JD. Editorial: Risks and benefits of celecoxib to prevent recurrent adenomas. N Engl J Med 2006 Aug 31;355(9):950-2.
• Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006 Sep;8(9):571-5.
• Sinicrope FA, Rego RL, Foster N, Sargent DJ, Windschitl HE, Burgart LJ, Witzig TE, Thibodeau SN. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 2006 Dec;101(12):2818-25. Epub 2006 Oct 6.
• Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006 Sep;131(3):729-37.
• Sinicrope FA, Rego RL, Halling KC, Foster NR, Sargent DJ, La Plant B, French AJ, Allegra CJ, Laurie JA, Goldberg RM, Witzig TE, Thibodeau SN. Thymidylate synthase expression in colon carcinomas with microsatellite instability. Clin Cancer Res 2006 May 1;12(9):2738-44.
• Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006 Sep;131(3):729-37.
• Taylor NP, Powell MA, Gibb RK, Rader JS, Huettner PC, Thibodeau SN, Mutch DG, Goodfellow PJ. MLH3 mutation in endometrial cancer. Cancer Res 2006 Aug 1;66(15):7502-8.
• Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, Kakar S, Fridlyand J, Snijders AM, Albertson DG, Thibodeau SN, Waldman FM. Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin Cancer Res 2006 Nov 1;12(21):6379-85.
• Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006 Feb;6(2):130-40. Review.
• Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006 Jul;38(7):787-93. Epub 2006 Jun 25.
• Yasui Y, Newcomb PA, Trentham-Dietz A, Egan KM. Familial relative risk estimates for use in epidemiologic analyses. Am J Epidemiol 2006 Oct 1;164(7):697-705. Epub 2006 Aug 21.
• Young J, Jass JR. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 2006 Oct;15(10):1778-84.
• Yu JH, Bigler J, Whitton J, Potter JD, Ulrich CM. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking. Am J Gastroenterol 2006 Jun;101(6):1313-9.

2005

• Artinyan A, Essani R, Lake J, Kaiser LAM, Vukasin P, Danenberg P, Danenberg K, Haile R, Beart RW. Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression. JOGS 2005;9:1216-21.
• Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN. Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer 2005;4(3):255-65. Review.
• Baudhuin LM, Mai M, French AJ, Kruckeberg KE, Swanson RL, Winters JL, Courteau LK, Thibodeau SN. Analysis of hMLH1 and hMSH2 gene dosage alterations in hereditary nonpolyposis colorectal cancer patients by novel methods. J Mol Diagn 2005 May;7(2):226-35. [Resource-inspired]
• Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR, Hopper JL, Diep A, Bapat B, Salem M, Seminara D, et al. for the Colon Cancer Family Registry. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 2005;293:799-809.
• Chia V, Newcomb PA. Environmental risk factors and colorectal neoplasia—recent developments. Current Colorectal Cancer Reports 2005;1(2):67-72.
• Coolbaugh-Murphy MI, Xu J, Ramagli LS, Brown BW, Siciliano MJ Microsatellite instability (MSI) increases with age in normal somatic cells. Mech Ageing Dev 2005 Oct;126(10):1051-9.
• Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control 2005;16:865-75.
• Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 2004; 127:714-722.
• Fazio L, Cotterchio M, Manno M, McLaughlin J, Gallinger S. Association between colonic screening, subject characteristics, and stage of colorectal cancer. Am J Gastroenterol 2005 Nov;100(11):2531-9.
• Gill S, Lindor NM, Burgart LJ, Smalley R, Leontovich O, French AJ, Goldberg RM, Sargent DJ, Jass JR, Hopper JL, Jenkins MA, Young J, Barker MA, Walsh MD, Ruszkiewicz AR, Thibodeau SN. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res 2005 Sep 15;11(18):6466-71.
• Gryfe R, Gallinger S. Germline PMS2 mutations: one hit or two? Gastroenterology 2005 May;128(5):1506-9. Review.
• Janes H, Pepe M, Kooperberg C, Newcomb P. Identifying target populations for screening or not screening using logic regression. Stat Med 2005 May 15;24(9):1321-38.
• Le Marchand L. The predominance of the environment over genes in cancer causation: implications for genetic epidemiology. Cancer Epidemiol Biomarkers Prev 2005 May;14(5):1037-9.
• Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005 Apr 27;293(16):1979-85.
• Morimoto LM, Newcomb PA, Bigler J, White E, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors. Cancer Epidemiol Biomarkers Prev 2005 Jun;14(6):1394-401.
• Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors. (United States). Cancer Causes Control 2005 Oct;16(8):917-27
• Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2005 May;14(5):1204-11.
• Potter JD. Epidemiology informing clinical practice: from bills of mortality to population laboratories. Nat Clin Pract Oncol 2005 Dec;2(12):625-34.
• Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 2005;29:221-6.
• Ramsey SD, Burke W, Pinsky L, Clarke L, Newcomb P, Khoury MJ. Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev 2005 Nov;14(11 Pt 1):2494-500.
• Thomas BC, Thibodeau SN, Lindor NM. Clinical Significance of tumor microsatellite instability and immunohistochemistry for mismatch repair deficiency in colorectal cancers. Current Colorectal Cancer Reports 2005 Vol 1:no. 1; 1-6.
• Thomas DC, Haile RW, Duggan D. Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet 2005 Sep;77(3):337-45.
• Woods MO, Hyde AJ, Curtis FK, Stuckless S, Green JS, Pollett AF, Robb JD, Green RC, Croitoru ME, Careen A, Chaulk JA, Jegathesan J, McLaughlin JR, Gallinger SS, Younghusband HB, Bapat BV, Parfrey PS. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clin Cancer Res 2005 Oct 1;11(19 Pt 1):6853-61.
• Young J, Barker MA, Simms LA, Walsh MD, Biden KG, Buchanan D, Buttenshaw R, Whitehall VL, Arnold S, Jackson L, Kambara T, Spring KJ, Jenkins MA, Walker GJ, Hopper JL, Leggett BA, Jass JR. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005 Mar;3(3):254-63.

2004

• Boland CR, Bigler J, Newcomb PA, Lampe JW, Potter JD. Evidence for an association between JC virus and colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2004 Dec;13(12):2285-6; author reply 2286.
• Coolbaugh-Murphy M, Maleki A, Ramagli L, Frazier M, Lichtiger B, Monckton DG, Siciliano MJ, Brown BW. Estimating mutant microsatellite allele frequencies in somatic cells by small-pool PCR. Genomics 2004 Aug;84(2):419-30.
• Croitoru ME, Cleary SP, Di Nicola N, Manno M, Selander T, Aronson M, Redston M, Cotterchio M, Knight J, Gryfe R, Gallinger S. Association between biallelic and monoallelic germline MYH mutations and colorectal cancer risk. J Natl Cancer Inst 2004;96(21):1631-4.
• Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espin E, Armengol M, Hamelin R, Yamamoto H, Hofstra RMW, Seruca R, Lindblom A, Peltomaki P, Thibodeau SN, Aaltonen LA, Schwartz S. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004 Sep;41(9):664-8.
• Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 2004; 127:714-722.
• Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004 Aug;53(8):1137-44.
• Kambara T, Whitehall VL, Spring KJ, Barker MA, Arnold S, Wynter CV, Matsubara N, Tanaka N, Young JP, Leggett BA, Jass JR. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 2004;40(1):1-9.
• Lindor, NM. Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes. Clin Gastroenterol Hepatol 2004 May;2(5):366-75.
• Lindor NM, Sloan J, Goldberg R, Bowen D, Nigon S, Roche A, Petersen G, Thibodeau SN, Burgart L, Leontovich O, Morlan BW. Colorectal tumour microsatellite instability test results: perspectives from patients. Hereditary Cancer Clin Pract 2004;2(2):69-75
• Madlensky L, Esplen MJ, Goel V. Reasons given by relatives of colorectal cancer patients for not undergoing screening. Prev Med 2004;39(4):643-8.
• McGivern A, Wynter CVA, Whitehall VLJ, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA, Young J, Jass JR. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 2004;3(2):101-7.
• Nakagawa H, Lockman JC, Frankel WL, Hampel H, Steenblock K, Burgart LJ, Thibodeau SN, de la Chapelle A. Mismatch repair gene PMS2: Disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 2004 Jul 15;64(14):4721-7. [Resource-inspired]
• Newcomb PA, Bush AC, Stoner GL, Lampe JW, Potter JD, Bigler J. No evidence of an association of JC virus and colon neoplasia. Cancer Epidemiol Biomarkers Prev 2004 Apr;13(4):662-6.
• Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004 May 1;159(9):882-90. Review.
• Sullivan T, Ashbury FD, Fallone CA, Naja F, Schabas R, Hebert PC, Hunt R, Jones N. Helicobacter pylori and the prevention of gastric cancer. Can J Gastroenterol 2004 May;18(5):295-302.
• Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004 Feb 18;96(4):261-8.
• Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, Petersen GM, Halling KC, French AJ, Johnson RA, Burgart LJ, Rabe K, Lindor NM, Thibodeau SN. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 2004 Jul;127(1):9-16. Erratum in: Gastroenterology. 2004 Nov;127(5):1651.
• Wynter CVA, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancers. Gut 2004; 53, 573-80.

2003

• Adem C, Soderberg CL, Cunningham JM, Reynolds C, Sebo TJ, Thibodeau SN, Hartmann LC, Jenkins RB. Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer 2003 Nov 20;107(4):580-2. [Resource-inspired]
• Campbell P, Cotterchio M, Klar N, McLaughlin J, Gallinger S. Colorectal cancer risk among post-menopausal hormone users in a population-based familial case-control study. Ann Epidemiol 2003;13(8):562.
• Esplen MJ, Urquhart C, Butler K, Gallinger S, Aronson M, Wong J. The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. J Psychosom Res 2003;55(5):427-35.
• Hahnloser D, Peterson GM, Rabe K, Snow K, Lindor NM, Boardman L, Koch B, Doescher D, Wang L, Steenblock K, Thibodeau SN. The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol Biomarkers Prev 2003;12(10):1023-8.
• Jass JR, Barker M, Fraser L, Walsh MD, Whitehall VLJ, Gabrielli B, Young J, Leggett BA. APC mutation and tumour budding in colorectal cancer. J Clin Pathol 2003;56(1):69-73.
• Kakar S, Burgart LJ, Thibodeau SN, Rabe KG, Peterson GM, Goldberg RM, Lindor NM. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer 2003;97(6):1421-7.
• Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V. Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med 2003;25(3):187-94.
• Madlensky L, McLaughlin J, Goel V. A comparison of self-reported colorectal cancer screening with medical records. Cancer Epidemiol Biomarkers Prev 2003;12(7):656-9.
• Morimoto LM, White E, Newcomb PA. Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 2003 Aug 1;158(3):259-63.
• Nadalin V, Cotterchio M, McKeown-Eyssen G, Gallinger S. Agreement between proxy- and case-reported information obtained using the self-administered Ontario Familial Colon Cancer Registry epidemiologic questionnaire. Chronic Dis Can 2003;24(1):1-8.
• Nakagawa H, Lockman JC, Frankel WL, Hampel H, Steenblock K, Burgart LJ, Thibodeau SN, de la Chapelle A. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 2004 Jul 15;64(14):4721-7.
• Newcomb PA, Storer B, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95(8):622-25.
• Pan K, Liu W, Lu YY, Zhang L, Li Z, Lu WL, Thibodeau SN, You WC. High throughput detection of microsatellite instability by denaturing high-performance liquid chromatography. Hum Mutat 2003 Nov;22(5):388-94.
• Ramsey SD, Burke W, Clarke L. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med 2003;5(5):353-63.
• Ramsey SD, Wilson S, Spencer A, Geidzinska A, Newcomb PA. Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives, and members of the community Results of focus group interviews. Community Genet 2003;6(1):29-36.
• Wang L, Cunningham JM, Winters JL, Guenther JC, French AJ, Boardman LA, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res 2003 Sep 1;63(17):5209-12.
• Wright FC, Law CH, Last L, Khalifa M, Arnaout A, Naseer Z, Klar N, Gallinger S, Smith AJ. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 2003;10(8):903-9.
• Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003;24(2):190-8.

2002

• Blaine S, Carroll J, Esplen MJ. Managing patients with a family history of cancer: psychosocial issues and primary care providers' evolving role in cancer genetics. Primary Psychiatry: Cancer Care Therapy: Psychosocial Issues in Cancer Genetics 2002;9(5):34-8.
• Easson AM, Cotterchio M, Crosby JA, Sutherland H, Dale D, Aronson M, Holowaty E, Gallinger S. A population-based study of the extent of surgical resection of potentially curable colon cancer. Ann Surg Oncol 2002;9(4):380-7.
• Jass JR, Walsh MD, Barker M, Simms LA, Young BA, Leggett BA. Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability (review). Eur J Cancer 2002;38(7):858-66.
• Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, Bapat B, Redston M, Thibodeau SN. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20(4):1043-8.
• Siegmund KD, Langholz B. Ascertainment bias in family-based case-control studies. Am J Epidemiol 2002;155(9):875-80.
• Whitehall VLJ, Wynter CVA, Walsh MD, Simms LA, Purdie D, Pandeya N, Young J, Meltzer SJ, Leggett BA, Jass JR. Morphological and molecular heterogeneity within nonmicrosatellite-high colorectal cancer. Cancer Res 2002;62(21):6011-14.
• Young J, Barker M, Fraser L, Walsh MD, Spring K, Biden KG, Simms LA, Leggett BA, Hopper JL, Jass JR. Mutation searching in colorectal cancer studies: experience with a denaturing high pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes. Pathology 2002;34(6):529-33.

2001

• Esplen MJ, Madlensky L, Butler K, McKinnon W, Wong J, Gallinger S. Motivations and psychosocial impact associated with genetic testing for HNPCC. Am J Med Genet 2001; 103(1):9-15.
• Garcia-Closas M, Egan KM, Abruzzo J, Newcomb PA, Titus-Ernstoff L, Franklin T, Bender PK, Beck JC, Le Marchand L, Lum A, Alavanja M, Hayes RB, Rutter J, Buetow K, Brinton LA, Rothman N. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 2001 Jun;10(6):687-96.
• Kim HS, Newcomb PA, Ulrich CM, Keener CL, Bigler J, Farin FM, Bostick RM, Potter JD. Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev 2001;10(8):869-74.
• Le Marchand L, Lum-Jones A, Saltzman B, Visaya V, Nomura AM, Kolonel LN. Feasibility of collecting buccal cell DNA by mail in a cohort study. Cancer Epidemiol Biomarkers Prev 2001 Jun;10(6):701-3.
• McIntosh M, Ramsey S, Berry K, Urban N. Parameter solicitation for planning cost effectiveness studies with dichotomous outcomes. Health Econ 2001;10:53-66.
• Nadalin V, Cotterchio M, McKeown-Eyssen G, Jazmaji V, Gallinger S. Validity of proxy reports obtained using the Ontario Familial Colon Cancer Registry epidemiologic questionnaire. Am J Epidemiol 2001;153:S88.
• Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001;135(8 Pt 1):577-88.
• Siegmund KD, Langholz B. Stratified case sampling and the use of family controls. Genet Epidemiol 2001;20(3):316-27.
• Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instabilty. Cancer Res 2001;61(3):827-30.
• Young J, Biden KG, Simms LA, Huggard P, Karamatic R, Eyre HJ, Sutherland GR, Herath N, Barker M, Anderson GJ, Fitzpatrick DR, Ramm GA, Jass JR, Leggett BA. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A 2001;98(1):265-70.
• Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin S-A, Borten MM, Stitz R, Searle J, Mckeone D, Fraser L, Purdie D, Podger K, Price R, Buttenshaw R, Walsh MD, Barker M, Leggett BA, Jass JR. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001;159(6):2107-16.

2000

• Biemer-Huttmann AE, Walsh MD, McGuckin MA, Simms LA, Young J, Leggett BA, Jass JR. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res 2000;6(5):1909-16.
• Clouston AD, Clouston DR, Jass JR. Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue. Histopathology. 2000 Dec;37(6):567.
• Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, Macey J, Holowaty E, Gallinger S. Ontario familial colon cancer registry: methods and first-year response rates. Chron Dis Can 2000;21(2):81-6.
• Jass JR, Constable L, Sutherland R, Winterford C, Walsh MD, Young J, Leggett BA. Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue. Histopathology. 2000 Feb;36(2):116-20.
• Jass JR. Familial colorectal cancer: pathology and molecular characteristics. Lancet Oncol 2000;1(4):220-6.
• Ramsey SD, McIntosh M, Etzioni R, Urban N. Simulation modeling of outcomes and cost effectiveness. Hematol Oncol Clin North Am 2000;14(4):925-38. Review.

1999

• Bapat BV, Madlensky L, Temple LKF, Hiruki T, Redston M, Baron DL, Xia L, Soravia C, Mitri A, Shen W, Gryfe R, Berk T, Chodirker B, Cohen Z, Gallinger S. Family history characteristics, tumor microsatellite instability and germline MSH2, and MLH1 mutations in hereditary colorectal cancer. Hum Genet 1999;104(2):167-76.
• Glanz K, Grove J, Le Marchand L, Nakamura A, Gotay C. Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):635-39.
• Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):329-36.
• Haile RW, Siegmund KD, Gauderman WJ, Thomas DC. Study-design issues in the development of the University of Southern California Consortium’s Colorectal Cancer Family Registry. J Natl Cancer Inst Monogr 1999;(26):89-93.
• Le Marchand L, Wilkens LR, Hankin JH, Kolonel LN, Lyu LC. Independent and joint effects of family history and lifestyle on colorectal cancer risk: implications for prevention. Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):45-51.
• Le Marchand L. Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans. J Natl Cancer Inst Monogr. 1999;(26):101-5.
• Seminara D, ed. Innovative study designs and analytic approaches to the genetic epidemiology of cancer. J Natl Cancer Inst Monogr 1999;(26):1-105. JNCI Web
• Siegmund KD, Whittemore AS, Thomas DC. Multistage sampling for disease family registries. J Natl Cancer Inst Monogr 1999;(26):43-8.

1998

• Lum A, Le Marchand L. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):719-24.